These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 15899702)

  • 1. Proteolytic susceptibility of the serine protease inhibitor trappin-2 (pre-elafin): evidence for tryptase-mediated generation of elafin.
    Guyot N; Zani ML; Berger P; Dallet-Choisy S; Moreau T
    Biol Chem; 2005 Apr; 386(4):391-9. PubMed ID: 15899702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase.
    Guyot N; Zani ML; Maurel MC; Dallet-Choisy S; Moreau T
    Biochemistry; 2005 Nov; 44(47):15610-8. PubMed ID: 16300411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of the inhibition of neutrophil proteinases by recombinant elafin and pre-elafin (trappin-2) expressed in Pichia pastoris.
    Zani ML; Nobar SM; Lacour SA; Lemoine S; Boudier C; Bieth JG; Moreau T
    Eur J Biochem; 2004 Jun; 271(12):2370-8. PubMed ID: 15182352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antibacterial and antifungal properties of trappin-2 (pre-elafin) do not depend on its protease inhibitory function.
    Baranger K; Zani ML; Chandenier J; Dallet-Choisy S; Moreau T
    FEBS J; 2008 May; 275(9):2008-20. PubMed ID: 18341586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family.
    Moreau T; Baranger K; Dadé S; Dallet-Choisy S; Guyot N; Zani ML
    Biochimie; 2008 Feb; 90(2):284-95. PubMed ID: 17964057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized elafin and trappin poorly inhibit the elastolytic activity of neutrophil elastase and proteinase 3.
    Nobar SM; Zani ML; Boudier C; Moreau T; Bieth JG
    FEBS J; 2005 Nov; 272(22):5883-93. PubMed ID: 16279952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone-tryptase interaction: H2A N-terminal tail removal and inhibitory activity.
    Fiorucci L; Erba F; Ascoli F
    Arch Biochem Biophys; 1997 Nov; 347(2):229-34. PubMed ID: 9367529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions.
    Zani ML; Tanga A; Saidi A; Serrano H; Dallet-Choisy S; Baranger K; Moreau T
    Biochem Soc Trans; 2011 Oct; 39(5):1441-6. PubMed ID: 21936830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate.
    Baranger K; Zani ML; Labas V; Dallet-Choisy S; Moreau T
    PLoS One; 2011; 6(6):e20976. PubMed ID: 21687692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of tryptase as mast cell-stabilizing agents in the human airways: effects of tryptase and other agonists of proteinase-activated receptor 2 on histamine release.
    He S; Aslam A; Gaça MD; He Y; Buckley MG; Hollenberg MD; Walls AF
    J Pharmacol Exp Ther; 2004 Apr; 309(1):119-26. PubMed ID: 14722328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
    van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
    J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of lung epithelial cells from protease-mediated injury by trappin-2 A62L, an engineered inhibitor of neutrophil serine proteases.
    Tanga A; Saidi A; Jourdan ML; Dallet-Choisy S; Zani ML; Moreau T
    Biochem Pharmacol; 2012 Jun; 83(12):1663-73. PubMed ID: 22465040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases.
    Zani ML; Baranger K; Guyot N; Dallet-Choisy S; Moreau T
    Protein Sci; 2009 Mar; 18(3):579-94. PubMed ID: 19241385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and characterization of recombinant gamma-tryptase.
    Yuan J; Beltman J; Gjerstad E; Nguyen MT; Sampang J; Chan H; Janc JW; Clark JM
    Protein Expr Purif; 2006 Sep; 49(1):47-54. PubMed ID: 16815034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase.
    He S; Gaça MD; Walls AF
    J Pharmacol Exp Ther; 1998 Jul; 286(1):289-97. PubMed ID: 9655871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic and thermodynamic analysis of leech-derived tryptase inhibitor interaction with bovine tryptase and bovine trypsin.
    Erba F; Fiorucci L; Sommerhoff CP; Coletta M; Ascoli F
    Biol Chem; 2000 Nov; 381(11):1117-22. PubMed ID: 11154069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of hepatitis B virus X protein with a serine protease, tryptase TL2 as an inhibitor.
    Takada S; Kido H; Fukutomi A; Mori T; Koike K
    Oncogene; 1994 Feb; 9(2):341-8. PubMed ID: 8290248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of biochemical properties of human airway tryptase isolated from mucoid sputum with those of lung mast cell tryptase].
    Yasuoka S; Tsuchihashi S; Kurokawa M; Terao T; Yoshinaga T; Kawano S; Takekawa Y; Nakayama T; Doi H; Ogawara M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jun; 34(6):678-84. PubMed ID: 8741534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The serine protease inhibitor trappin-2 is present in cartilage and synovial fluid in osteoarthritis.
    Jaovisidha K; Etim A; Yamakawa K; Masuda I; Gohr CM; Wakim BT; Boonapatcharoen N; Ninomiya J; Rosenthal AK
    J Rheumatol; 2006 Feb; 33(2):318-25. PubMed ID: 16465664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils.
    Matsunaga Y; Kido H; Kawaji K; Kamoshita K; Katunuma N; Ogura T
    Arch Biochem Biophys; 1994 Jul; 312(1):67-74. PubMed ID: 8031148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.